Overview

Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201

Status:
Terminated
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
Compare the long-term safety of pradefovir to adefovir dipivoxyl
Phase:
Phase 2
Details
Lead Sponsor:
Bausch Health Americas, Inc.
Valeant Pharmaceuticals International, Inc.
Treatments:
Adefovir
Adefovir dipivoxil
Pradefovir